Nezulcitinib
Product Specifications
CAS Number
2412496-23-0
Target
Others|||JAK
Related Pathways
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Chromatin/Epigenetic|||Angiogenesis|||Stem Cells|||Others
Bioactivity
Nezulcitinib (TD-0903) is an inhaled, lung-selective pan-Janus kinase (JAK) inhibitor used to study COVID-19-associated acute lung injury and impaired oxygenation.
Smiles
C(=O)([C@@H]1CC=2NC(C=3C=4C(NN3)=CC(=CC4)C5=C(CC)C=C(O)C=C5)=NC2CN1C(C)C)N6CC(N(C)C)C6
Molecular Formula
C30H37N7O2
Molecular Weight
527.66
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1186439-01 0.5 mg (E-Coli)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details 
MBS1186439-02 0.05 mg (Baculovirus)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details 
MBS1186439-03 0.5 mg (Yeast)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details MBS1186439-04 0.05 mg (Mammalian-Cell)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details 
MBS1186439-05 1 mg (E-Coli)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details MBS1186439-06 0.1 mg (Baculovirus)
Recombinant Enterobacteria phage phiX174 Lysis protein E (E), partial
Ask
View Details